Atherosclerotic cardiovascular disease in rheumatoid arthritis.

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The past 3 years have seen a remarkable growth in the interest of cardiovascular disease in rheumatoid arthritis. There have been studies published documenting an increased incidence and prevalence of cardiovascular conditions in patients with rheumatoid arthritis compared with individuals without rheumatoid arthritis. There has also been interest in the occurrence of cardiovascular risk factors in rheumatoid arthritis and in the role of antirheumatic therapy, including cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs, methotrexate, corticosteroids, and tumor necrosis factor inhibitors. A number of studies using noninvasive means to detect atherosclerosis have shown that patients with rheumatoid arthritis may be prone to atherosclerosis. This information should be important to physicians who provide care to patients with rheumatoid arthritis, given the difficulty of recognizing cardiovascular signs and symptoms among patients with the disease.

Original languageEnglish (US)
Pages (from-to)278-286
Number of pages9
JournalCurrent Rheumatology Reports
Volume5
Issue number4
StatePublished - Aug 2003

Fingerprint

Rheumatoid Arthritis
Cardiovascular Diseases
Atherosclerosis
Cyclooxygenase 2
Methotrexate
Signs and Symptoms
Patient Care
Adrenal Cortex Hormones
Anti-Inflammatory Agents
Tumor Necrosis Factor-alpha
Physicians
Incidence
Growth
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Rheumatology

Cite this

Atherosclerotic cardiovascular disease in rheumatoid arthritis. / Del Rincon, Inmaculada; Escalante, Agustin.

In: Current Rheumatology Reports, Vol. 5, No. 4, 08.2003, p. 278-286.

Research output: Contribution to journalArticle

@article{3076c804a8dc414a8b4cc74e19fb7172,
title = "Atherosclerotic cardiovascular disease in rheumatoid arthritis.",
abstract = "The past 3 years have seen a remarkable growth in the interest of cardiovascular disease in rheumatoid arthritis. There have been studies published documenting an increased incidence and prevalence of cardiovascular conditions in patients with rheumatoid arthritis compared with individuals without rheumatoid arthritis. There has also been interest in the occurrence of cardiovascular risk factors in rheumatoid arthritis and in the role of antirheumatic therapy, including cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs, methotrexate, corticosteroids, and tumor necrosis factor inhibitors. A number of studies using noninvasive means to detect atherosclerosis have shown that patients with rheumatoid arthritis may be prone to atherosclerosis. This information should be important to physicians who provide care to patients with rheumatoid arthritis, given the difficulty of recognizing cardiovascular signs and symptoms among patients with the disease.",
author = "{Del Rincon}, Inmaculada and Agustin Escalante",
year = "2003",
month = "8",
language = "English (US)",
volume = "5",
pages = "278--286",
journal = "Current Rheumatology Reports",
issn = "1523-3774",
publisher = "Current Science, Inc.",
number = "4",

}

TY - JOUR

T1 - Atherosclerotic cardiovascular disease in rheumatoid arthritis.

AU - Del Rincon, Inmaculada

AU - Escalante, Agustin

PY - 2003/8

Y1 - 2003/8

N2 - The past 3 years have seen a remarkable growth in the interest of cardiovascular disease in rheumatoid arthritis. There have been studies published documenting an increased incidence and prevalence of cardiovascular conditions in patients with rheumatoid arthritis compared with individuals without rheumatoid arthritis. There has also been interest in the occurrence of cardiovascular risk factors in rheumatoid arthritis and in the role of antirheumatic therapy, including cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs, methotrexate, corticosteroids, and tumor necrosis factor inhibitors. A number of studies using noninvasive means to detect atherosclerosis have shown that patients with rheumatoid arthritis may be prone to atherosclerosis. This information should be important to physicians who provide care to patients with rheumatoid arthritis, given the difficulty of recognizing cardiovascular signs and symptoms among patients with the disease.

AB - The past 3 years have seen a remarkable growth in the interest of cardiovascular disease in rheumatoid arthritis. There have been studies published documenting an increased incidence and prevalence of cardiovascular conditions in patients with rheumatoid arthritis compared with individuals without rheumatoid arthritis. There has also been interest in the occurrence of cardiovascular risk factors in rheumatoid arthritis and in the role of antirheumatic therapy, including cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs, methotrexate, corticosteroids, and tumor necrosis factor inhibitors. A number of studies using noninvasive means to detect atherosclerosis have shown that patients with rheumatoid arthritis may be prone to atherosclerosis. This information should be important to physicians who provide care to patients with rheumatoid arthritis, given the difficulty of recognizing cardiovascular signs and symptoms among patients with the disease.

UR - http://www.scopus.com/inward/record.url?scp=0642274844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0642274844&partnerID=8YFLogxK

M3 - Article

C2 - 14531955

AN - SCOPUS:0642274844

VL - 5

SP - 278

EP - 286

JO - Current Rheumatology Reports

JF - Current Rheumatology Reports

SN - 1523-3774

IS - 4

ER -